Value of bretylium tosylate in controlling arrhythmia
Szulc, E.J.
Wiadomosci Lekarskie 24(18): 1783-1785
1971
ISSN/ISBN: 0043-5147 PMID: 5117449 Document Number: 31281
Document emailed within 1 workday
Related Documents
Steffen, V.; Assmann, I.; Fiehring, H. 1976: Clinical experiences with bretylium tosylate Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(17): 684-688Borkowski, P.J. 1970: Bretylium tosylate as an antiarrhythmic agent Kardiologia Polska 13(2): 195-198
Dvorák, K.; Vavros, B.; Cerný, J. 1975: Bretylium tosylate--a new antiarrhythmic agent with antifibrillatory effect Vnitrni Lekarstvi 21(3): 278-284
Lee, Y.C.; Malick, A.W.; Amann, A.H.; Baaske, D.M.; Shah, J.J.; Wagenknecht, D.M.; Carter, J.E. 1981: Bretylium tosylate intravenous admixture compatibility. II: Dopamine, lidocaine, procainamide, and nitroglycerin American Journal of Hospital Pharmacy 38(2): 183-187
Dhurandhar, R.W.; Pickron, J.; Goldman, A.M. 1980: Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction Heart and Lung: the Journal of Critical Care 9(2): 265-270
Nakamura, H. 2004: Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65
Yazaki, Y.; Ohta, A.; Tsunakawa, H.; Harumi, K. 1984: Diagnosis of arrhythmia. a. Invasive arrhythmia analysis and provocation tests Nihon Rinsho. Japanese Journal of Clinical Medicine 42(12): 2676-2686
Mazur, N.A.; Kurbanov, R.D. 1984: Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations Terapevticheskii Arkhiv 56(9): 67-70
Bonhorst, D. 1992: Choice of anti-arrhythmia agents: the arrhythmia-patient binomial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 387-389
Lishmanov, I.B.; Maslov, L.N.; Krylatov, A.V.; Ugdyzhekova, D.S.; Gilligan, P.; Tam, S.W. 2000: The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands Eksperimental'naia i Klinicheskaia Farmakologiia 63(2): 39-43
Hohnloser, S.H.; Meinertz, T.; Mehender, M.; Geibel, A.; Just, H. 1988: Induction and increase of cardiac arrhythmia by anti-arrhythmia agents Der Internist 29(5): 338-344
Parker, T.S.; Macri, J.R.; Jenden, D.J. 1976: A new neuromuscular blocking agent: 1-methyl, 1(2-hydroxyethyl) aziridinium tosylate (cyclocholine) Proceedings of the Western Pharmacology Society 19: 79-86
Handa, S.; Mitamura, H. 1980: Arrhythmia and differential diagnosis: supraventricular arrhythmia Nursing Technique 26(2): 166-172
Norman, J.; Whitwam, J.G. 1973: The use of practolol and bretylium to produce cardiac sympathetic nerve block British Journal of Anaesthesia 45(8): 925
Priola, D.V.; Weiss, G.K.; Spurgeon, H.A. 1977: Preferential blockade of chronotropic responses to cardiac sympathetic nerve stimulation with bretylium Proceedings of the Western Pharmacology Society 20: 421-426
Cunnane, T.; Draper, A.J.; Redfern, P.H. 1975: The effects of amantadine, tranylcypromine, amphetamine and tyramine on the response of the rat anococcygeus muscle after bretylium Journal of Pharmacy and Pharmacology 27(Suppl 2): 14p
Haasio, J.; Pitkänen, M.T.; Kyttä, J.; Rosenberg, P.H. 1990: Treatment of bupivacaine-induced cardiac arrhythmias in hypoxic and hypercarbic pigs with amiodarone or bretylium Regional Anesthesia 15(4): 174-179